Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management

BJU International

Volumn 108, Issue 2 B, 2011, Pages

  Maruschke, Matthias ^a   Reuter, D ^a   Koczan, D ^a   Hakenberg, O W ^a   Thiesen, H J ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

biostatistical management; gene expression; gene set enrichment analysis; renal cell carcinoma

Indexed keywords

ARTICLE; BIOSTATISTICS; CANCER GRADING; CANCER SURGERY; CANCER SURVIVAL; CANCER TISSUE; CLEAR CELL CARCINOMA; CLEAR CELL RENAL CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENE SET ENRICHMENT ANALYSIS; GENETIC ANALYSIS; GENETIC MARKER; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; KIDNEY SURGERY; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME; TISSUE MICROARRAY;

ALGORITHMS; CARCINOMA, RENAL CELL; CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; DATA INTERPRETATION, STATISTICAL; DATABASES, GENETIC; EFFICIENCY; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; KIDNEY NEOPLASMS; MICROARRAY ANALYSIS; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 79960077332     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09794.x     Document Type: Article

References (27)

1. Jemal A, Siegel R, Ward E, et al,. Cancer statistics, 2006. CA Cancer J Clin 2006; 56: 106-30
2. Amin MB, Amin MB, Tamboli P, et al,. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol 2002; 26: 281-91 (Pubitemid 34184451)
3. Lam JS, Shvarts O, Leppert JT, Figlin RA, Belldegrun AS,. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy. J Urol 2005; 173: 1853-62 (Pubitemid 40675199)
4. Janzen NK, Kim HL, Figlin RA, Belldegrun AS,. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol Clin North Am 2003; 30: 843-52 (Pubitemid 37485197)
5. Hudes G, Carducci M, Tomczak P, et al,.; Global ARCC Trial. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl J Med 2007; 356: 2271-81 (Pubitemid 46849157)
6. Motzer RJ, Hutson TE, Tomczak P, et al,. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 2007; 356: 115-24 (Pubitemid 46089672)
7. Escudier B, Eisen T, Stadler WM, et al,.; TARGET Study Group. Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 2007; 356: 125-34 (Pubitemid 46089673)
8. Eichelberg C, Junker K, Ljungberg B, Moch H,. Diagnostic and prognostic molecular markers for renal cell carcinoma: a critical appraisal of the current state of research and clinical applicability. Eur Urol 2009; 55: 851-63. Epub 2009 Jan 13
9. Doughtery ER, Jianping H, Bittner ML,. Validation of computational methods in genomics. Curr Genomics 2007; 8: 1-19 (Pubitemid 46488271)
10. Subramanian A, Tamayo P, Mootha VK, et al,. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102: 15545-50 (Pubitemid 41528093)
11. Eisen MB, Spellman PT, Brown PO, Botstein D,. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998; 95: 14863-8 (Pubitemid 29003722)
12. Kang HC, Kim IJ, Park JH, et al,. Identification of genes with differential expression in acquired drug-resistant gastric cancer cells using high-density oligonucleotide microarrays. Clin Cancer Res 2004; 10: 272-84 (Pubitemid 38114190)
13. Zhan F, Huang Y, Colla S, et al,. The molecular classification of multiple myeloma. Blood 2006; 108: 2020-8 (Pubitemid 44395016)
14. Mense SM, Sengupta A, Zhou M, et al,. Gene expression profiling reveals the profound upregulation of hypoxia-responsive genes in primary human astrocytes. Physiol Genomics 2006; 25: 435-49 (Pubitemid 43764765)
15. Xie X, Lu J, Kulbokas EJ, et al,. Systematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammals. Nature 2005; 434: 338-45 (Pubitemid 40469170)
16. Semenza GL,. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003; 3: 721-32 (Pubitemid 37328811)
17. Schofield CJ, Ratcliffe PJ,. Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 2004; 5: 343-54 (Pubitemid 38579472)
18. Zagõrska A, Dulak J,. HIF-1: the knowns and unknowns of hypoxia sensing. Acta Biochim Pol 2004; 51: 563-85 (Pubitemid 39296914)
19. Acker T, Acker H,. Cellular oxygen sensing need in CNS function: physiological and pathological implications. J Exp Biol 2004; 207: 3171-88 (Pubitemid 39275292)
20. Larsen AK, Escargueil AE, Skladanowski A,. Resistance mechanisms associated with altered intracellular distribution of anticancer agents. Pharmacol Ther 2000; 85: 217-29 (Pubitemid 30160791)
21. Blanc-Brude OP, Yu J, Simosa H, Conte MS, Sessa WC, Altieri DC,. Inhibitor of apoptosis protein survivin regulates vascular injury. Nat Med 2002; 8: 987-94 (Pubitemid 35033703)
22. Rhodes DR, Yu J, Shanker K, et al,. Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc Natl Acad Sci USA 2004; 101: 9309-14 (Pubitemid 38812872)
23. Greenbaum S, Lazorchak AS, Zhuang Y,. Differential functions for the transcription factor E2A in positive and negative gene regulation in pre-B lymphocytes. J Biol Chem 2004; 279: 45028-35 (Pubitemid 39430917)
24. Nam D, Kim SY,. Gene-set approach for expression pattern analysis. Brief Bioinform 2008; 9: 189-97 (Pubitemid 351637941)
25. Kim SY, Volsky DJ,. PAGE: parametric analysis of gene set enrichment. BMC Bioinformatics 2005; 6: 144
26. Raghavan N, De Bondt AM, Talloen W, Moechars D, Göhlmann HW, Amaratunga D,. The high-level similarity of some disparate gene expression measures. Bioinformatics 2007; 23: 3032-8 (Pubitemid 350162868)
27. Aris VM, Cody MJ, Cheng J, et al,. Noise filtering and nonparametric analysis of microarray data underscores discriminating markers of oral, prostate, lung, ovarian and breast cancer. BMC Bioinformatics 2004; 5: 185